Physician profile
Sreedevi Reddy
NPI 1437169067
$27,688.01
in general payments reported to CMS, 2019-2025
59 companies · $3,255 in 2025
The $3,255 reported for 2025 was more than what 84% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,766 · 2020: $596 · 2021: $2,372 · 2022: $2,433 · 2023: $3,946 · 2024: $9,319 · 2025: $3,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,678 · Consulting Fee: $5,700 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,035 · Gift: $59.40 · Education: $48.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,677.94 |
| Consulting Fee | $5,700.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,035.00 |
| Gift | $59.40 |
| Education | $48.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $6,511.04 | 2019-2025 | Korlym |
| Echosens North America, INC. | $6,300.00 | 2023-2025 | Fibroscan, Fibroscan |
| Novartis Pharmaceuticals Corporation | $1,444.62 | 2021-2023 | |
| Lilly USA, LLC | $1,238.39 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Rhythm Pharmaceuticals, INC. | $1,095.36 | 2022-2024 | Imcivree, Imcivree |
| Abbott Laboratories | $873.22 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2, Aveir |
| Amgen INC. | $732.09 | 2019-2025 | Evenity, Tepezza, Prolia |
| Recordati_rare_diseases_inc. | $674.33 | 2023-2025 | Isturisa, Signifor Lar |
| Astrazeneca Pharmaceuticals Lp | $611.91 | 2019-2024 | Farxiga |
| Novo Nordisk INC | $611.48 | 2019-2024 | Ozempic, Rybelsus, Wegovy |
| Insulet Corporation | $589.72 | 2019-2024 | Omnipod |
| Mannkind Corporation | $559.13 | 2019-2024 | Afrezza |
| Abbvie INC. | $502.95 | 2019-2025 | |
| Dexcom, INC. | $451.73 | 2019-2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $447.83 | 2019-2025 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $416.59 | 2019-2024 | Jardiance |
| Beta Bionics, INC. | $337.87 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Madrigal Pharmaceuticals | $334.82 | 2024-2025 | Rezdiffra, Resmetirom |
| Xeris Pharmaceuticals, INC. | $297.44 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Amneal Pharmaceuticals LLC | $288.47 | 2022-2025 | Unithroid |
| Cequr Corporation | $259.58 | 2022-2025 | Cequr Simplicity |
| Alexion Pharmaceuticals, INC. | $255.90 | 2019-2025 | Strensiq |
| Antares Pharma, INC. | $249.45 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Radius Health, INC. | $240.15 | 2019-2025 | Tymlos |
| Neurocrine Biosciences, INC. | $202.53 | 2024-2025 | |
| Sequel Med Tech, LLC | $201.30 | 2025 | Twiist |
| Medtronic, INC. | $165.84 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Medtronic Minimed, INC. | $158.15 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.42 | 2023-2025 | |
| Lifescan, INC. | $135.50 | 2019-2020 | |
| Amarin Pharma, INC. | $132.67 | 2020-2023 | |
| Horizon Therapeutics Plc | $129.66 | 2022 | |
| Ascendis Pharma Endocrinology INC | $128.87 | 2024-2025 | Yorvipath |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Tandem Diabetes Care, INC. | $114.79 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Halozyme INC | $78.91 | 2023 | |
| Tolmar, INC. | $67.23 | 2024-2025 | Jatenzo |
| Janssen Pharmaceuticals, INC | $64.83 | 2019 | |
| Valeritas, INC. | $51.81 | 2019 | |
| Astellas Pharma US INC | $50.44 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $42.90 | 2019-2020 | |
| Sandoz INC. | $30.98 | 2025 | |
| Kyowa Kirin, INC. | $29.50 | 2024 | Crysvita |
| Merck Sharp & Dohme LLC | $26.19 | 2019-2020 | |
| Shire North American Group INC | $24.59 | 2019 | |
| Vivus LLC | $23.62 | 2019 | |
| Chiesi USA, INC. | $23.59 | 2024 | Mycapssa |
| Zealand Pharma US, INC. | $21.81 | 2021 | |
| Amryt Pharma Holdings Ltd | $21.47 | 2023 | Mycapssa |
| Exact Sciences Corporation | $19.93 | 2025 | Cologuard Collection Kit |
| Averitas Pharma INC. | $19.53 | 2024 | Qutenza |
| Acerus Pharmaceuticals Corporation | $18.46 | 2022 | |
| Almatica Pharma LLC | $16.71 | 2024 | Teriparatide |
| Companion Medical, INC. | $16.13 | 2019 | |
| Acella Pharmaceuticals, LLC | $13.97 | 2025 | NP Thyroid 60 |
| Clarus Therapeutics INC. | $13.90 | 2021 | |
| Endo Pharmaceuticals INC. | $13.27 | 2019 | |
| Esperion Therapeutics, INC. | $12.74 | 2023 | Nexletol |
| Intuity Medical INC | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sreedevi Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.